Pharmacogenomics of selective serotonin reuptake inhibitor treatment for major depressive disorder: genome-wide associations and functional genomics

A genome-wide association (GWA) study of treatment outcomes (response and remission) of selective serotonin reuptake inhibitors (SSRIs) was conducted using 529 subjects with major depressive disorder. While no SNP associations reached the genome-wide level of significance, 14 SNPs of interest were i...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The pharmacogenomics journal 2013-10, Vol.13 (5), p.456-463
Hauptverfasser: Ji, Y, Biernacka, J M, Hebbring, S, Chai, Y, Jenkins, G D, Batzler, A, Snyder, K A, Drews, M S, Desta, Z, Flockhart, D, Mushiroda, T, Kubo, M, Nakamura, Y, Kamatani, N, Schaid, D, Weinshilboum, R M, Mrazek, D A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!